Table 2

Distribution of several clinicopathological parameters and levels of soluble carcinoembryonic antigen (CEA) in relation to the presence of mRNA markers in plasma

Pathological parametern*One or both markers positiveBoth markers negativep Value
*Number of patients studied.
LNM, lymph node metastases; VI, vascular invasion.
LNM53
    Positive22 10.06
    Negative22 8
VI53
    Positive25 20.07
    Negative19 7
Stage53
    C+D23 10.03
    A+B21 8
CEA38
    High14 00.03
    Low17 7
Age53
    Mean7175NS
    Range39–8655–83
Sex53
    Male30 6NS
    Female14 3
Size53
    Mean 4.95.9NS
    Range2–124–12
Tumour side53
    Left34 6NS
    Other10 3
Polyps53
    Positive18 6NS
    Negative26 3
Grade53
    I11 2NS
    II27 4
    III 6 3